1. 356 Baseline PD-L1 expression and tumor immune infiltration is associated with clinical response in patients with r/r DLBCL treated with DPX-Survivac, low-dose cyclophosphamide and pembrolizumab. (9th November 2020) Authors: Berinstein, Neil; Bence-Bruckler, Isabelle; Forward, Nick; Laneuville, Pierre; Mangel, Joy; Stewart, Douglas; Amitai, Irina; Klein, Gail; Pennell, Nancy; Rashedi, Iran; Roos, Kim; Bramhecha, Yogesh; Conlon, Rebekah Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A217 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 356 Baseline PD-L1 expression and tumor immune infiltration is associated with clinical response in patients with r/r DLBCL treated with DPX-Survivac, low-dose cyclophosphamide and pembrolizumab. (9th November 2020) Authors: Berinstein, Neil; Bence-Bruckler, Isabelle; Forward, Nick; Laneuville, Pierre; Mangel, Joy; Stewart, Douglas; Amitai, Irina; Klein, Gail; Pennell, Nancy; Rashedi, Iran; Roos, Kim; Bramhecha, Yogesh; Conlon, Rebekah Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 3 Page Start: A381 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Bone mineral density utilization in patients with newly diagnosed multiple myeloma. Issue 4 (21st June 2016) Authors: Muchtar, Eli; Dagan, Adi; Robenshtok, Eyal; Shochat, Tzippy; Oniashvili, Nino; Amitai, Irina; Raanani, Pia; Magen, Hila Journal: Hematological oncology Issue: Volume 35:Issue 4(2017:Dec.) Page Start: 703 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Changes in primary outcome and sample size measures after initiation of accrual among trials supporting approval of drugs for hematological malignancies by the US food and drug administration. Issue 9 (28th July 2020) Authors: Amitai, Irina; Raanani, Pia; Shepshelovich, Daniel Journal: Leukemia & lymphoma Issue: Volume 61:Issue 9(2020) Page Start: 2216 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Current challenges and opportunities in treating adult patients with Philadelphia‐negative acute lymphoblastic leukaemia. (26th October 2017) Authors: Wolach, Ofir; Amitai, Irina; DeAngelo, Daniel J. Journal: British journal of haematology Issue: Volume 179:Number 5(2017) Page Start: 705 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Human herpes virus 6 reactivation following autologous hematopoietic cell transplantation – a single-center experience. Issue 9 (29th July 2019) Authors: Shargian-Alon, Liat; Yahav, Dafna; Rozovski, Uri; Dovrat, Sara; Amitai, Irina; Sela-Navon, Michal; Pasvolsky, Oren; Raanani, Pia; Yeshurun, Moshe Journal: Leukemia & lymphoma Issue: Volume 60:Issue 9(2019) Page Start: 2230 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Obinutuzumab‐related adverse events: A systematic review and meta‐analysis. Issue 2 (10th December 2020) Authors: Amitai, Irina; Gafter‐Gvili, Anat; Shargian‐Alon, Liat; Raanani, Pia; Gurion, Ronit Journal: Hematological oncology Issue: Volume 39:Issue 2(2021) Page Start: 215 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Patient‐reported fatigue refines prognosis in higher‐risk myelodysplastic syndromes (MDS): a MDS‐CAN study. (31st May 2021) Authors: Amitai, Irina; Geddes, Michelle; Zhu, Nancy; Keating, Mary‐Margaret; Sabloff, Mitchell; Christou, Grace; Leber, Brian; Khalaf, Dina; Leitch, Heather A.; St‐Hilaire, Eve; Finn, Nicholas; Shamy, April; Yee, Karen; Storring, John; Nevill, Thomas; Delage, Robert; Elemary, Mohamed; Banerji, Versha; Ch... Journal: British journal of haematology Issue: Volume 194:Number 2(2021) Page Start: 319 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. PET-adapted therapy for advanced Hodgkin lymphoma – systematic review. (3rd June 2018) Authors: Amitai, Irina; Gurion, Ronit; Vidal, Liat; Dann, Eldad J.; Raanani, Pia; Gafter-Gvili, Anat Journal: Acta oncologica Issue: Volume 57:Number 6(2018) Page Start: 765 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Risk factors for high‐dose methotrexate associated acute kidney injury in patients with hematological malignancies. Issue 4 (24th June 2020) Authors: Amitai, Irina; Rozovski, Uri; El‐Saleh, Reem; Shimony, Shai; Shepshelovich, Daniel; Rozen‐Zvi, Benaya; Raanani, Pia; Gafter‐Gvili, Anat; Gurion, Ronit Journal: Hematological oncology Issue: Volume 38:Issue 4(2020) Page Start: 584 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗